ZBTB46 and lung carcinoma: As presented in Fig. 4a, it was observed that ZBTB46 expression correlated significantly positively with all types of immune cells analyzed, including B-cells, CD8+ T-cells, CD4+ T-cells, macrophages, neutrophils, and dendritic cells in lung cancer.